Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC [Phase 2]
A Phase 2 trial evaluating MR-guided adaptive SBRT of the primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma has …
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas. [Phase 1, Phase 2]
A Phase 1/2 trial evaluating neoadjuvant and adjuvant nivolumab with BMS-813160, with or without GVAX, for locally advanced pancreatic ducta…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab [Phase 2]
A Phase 2 basket trial evaluating the combination of niraparib and dostarlimab across multiple cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
Clinical trial update on adding paricalcitol to chemotherapy for previously untreated metastatic pancreatic ductal adenocarcinoma; the Phase…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) [Phase 1, Phase 2]
Phase 1/2 clinical trial update reporting results from multiple immunotherapy-based treatment combinations in participants with metastatic p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection
A completed study examining genetic changes and gene characteristics in pancreatic ductal adenocarcinoma patients to help tailor treatments.
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 study of Botensilimab in metastatic pancreatic ductal adenocarcinoma is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer [Phase 1, Phase 2]
ClinicalTrials.gov reports an ongoing Phase 1/2 study evaluating sonoporation in combination with chemotherapy for locally advanced or metas…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update reports on the combination of MGC018 and MGD019 in participants with advanced solid tumors, including castration-r…
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins. [EARLY_Phase 1]
An early-phase study evaluating the Ga-68 labeled FF58 radiotracer in selected solid tumors overexpressing integrins has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating mitazalimab in combination with chemotherapy for metastatic pancreatic ductal ad…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer [Phase 1, Phase 2]
This completed Phase 1/2 study evaluated the safety and tolerability of combining epigenetic and immunomodulating drugs with standard chemot…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas [Phase 3]
Phase 3 clinical trial evaluating Glubran 2, a modified cyanoacrylate tissue adhesive, for use in soft pancreas during pancreatic and periam…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating JDB153 in combination with Serplulimab for refractory pancreatic ductal adenocarcinoma; the study is not…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma [Phase 1]
Phase 1 clinical trial update evaluating the combination of ivosidenib with mFOLFIRINOX in patients with resectable pancreatic ductal adenoc…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) [Phase 1, Phase 2]
A CD318-targeted CAR-T cell therapy (ResCPa) is being studied in pancreatic cancer patients in Phase 1 and Phase 2, and the trial is not yet…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours [Phase 1]
A Phase 1 study of [225Ac]-FPI-2059 in adults with solid tumours was terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating niraparib in combination with dostarlimab for germline or somatic BRCA1/2 and PALB2-mutated metastatic pancreatic c…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating first-line L-glutamine in combination with gemcitabine and nab-paclitaxel for advanced pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Early Detection of PDAC in Patients With Chronic Pancreatitis
A completed clinical trial evaluating early detection approaches for pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer [Phase 1]
This document updates the status of a Phase 1 trial evaluating Pyrvinium Pamoate for safety and tolerability in pancreatic cancer. The study…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Plasma Biomarkers P-DAC, V1
Update on a terminated clinical trial (P-DAC, V1) evaluating plasma biomarkers for pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: OSCAR I STUDY - The ONCObind CTC Removal Study [NA]
The OSCAR I study evaluating the ONCObind CTC removal system for pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: DC Vaccine in Pancreatic Cancer [Phase 1]
This Phase 1 trial update shows a completed study of a dendritic cell vaccine in pancreatic ductal adenocarcinoma, sponsored by the Universi…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: CART-meso in Mesothelin Expressing Cancers [Phase 1]
Phase 1 update on CART-meso, a mesothelin-targeted CAR T-cell therapy, tested in mesothelin-expressing cancers including metastatic pancreat…